Large differencies in age-specific survival in multiple myeloma in the nordic countries
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu dopisy, práce podpořená grantem
Grantová podpora
856620
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
PubMed
38467614
PubMed Central
PMC10928156
DOI
10.1038/s41408-024-01026-6
PII: 10.1038/s41408-024-01026-6
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- mnohočetný myelom * epidemiologie terapie MeSH
- rizikové faktory MeSH
- věkové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Skandinávie a severské státy epidemiologie MeSH
Department of Hematology Rigshospitalet Copenhagen Denmark
Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany
Hematology and Transfusion Medicine Department of Laboratory Medicine BMC B13 221 84 Lund Sweden
Zobrazit více v PubMed
Hemminki K, Försti A, Houlston R, Sud A. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases. Int J Cancer. 2021;149:1980–96. doi: 10.1002/ijc.33762. PubMed DOI
Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962–72. doi: 10.1182/blood-2007-10-078022. PubMed DOI PMC
Ruotsalainen J, Lehmus L, Putkonen M, Lievonen J, Kallio A, Raittinen P, et al. Recent trends in incidence, survival and treatment of multiple myeloma in Finland - a nationwide cohort study. Ann Hematol. 2023. (in press). PubMed PMC
Blimark CH, Turesson I, Genell A, Ahlberg L, Björkstrand B, Carlson K, et al. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 2018;103:506–13. doi: 10.3324/haematol.2017.178103. PubMed DOI PMC
Blimark CH, Vangsted AJ, Klausen TW, Gregersen H, Szabo AG, Hermansen E, et al. Outcome data from >10,000 multiple myeloma patients in the Danish and Swedish national registries. Eur J Haematol. 2022;108:99–108. doi: 10.1111/ejh.13707. PubMed DOI
Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, et al. Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden. Haematologica. 2023;108:1640–51. doi: 10.3324/haematol.2021.280424. PubMed DOI PMC
Hemminki K, Försti A, Hansson M. Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016. Sci Rep. 2021;11:17272. doi: 10.1038/s41598-021-96804-8. PubMed DOI PMC
Hemminki K, Hemminki J, Försti A, Sud A. Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia. 2023;37:854–63. doi: 10.1038/s41375-023-01852-w. PubMed DOI PMC
Pulte D, Jansen L, Brenner H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood cancer J. 2020;10:56. doi: 10.1038/s41408-020-0323-4. PubMed DOI PMC
Larønningen SAG, Bray F, Engholm G, Ervik M, Guðmundsdóttir EM, Gulbrandsen J, et al. NORDCAN: cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 9.3 (02.10.2023). 2023.
Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, et al. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015;171:189–96. doi: 10.1111/bjh.13537. PubMed DOI
Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic cancer registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–55. doi: 10.1080/0284186X.2017.1407039. PubMed DOI
Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians–a national Danish project. Health Policy. 2012;105:65–70. doi: 10.1016/j.healthpol.2011.11.001. PubMed DOI
Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, et al. The Danish National Multiple Myeloma Registry. Clin Epidemiol. 2016;8:583–7. doi: 10.2147/CLEP.S99463. PubMed DOI PMC
Vikkula J, Uusi-Rauva K, Ranki T, Toppila I, Aalto-Setälä M, Pousar K, et al. Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland. Future Oncol. 2023;19:2029–43. doi: 10.2217/fon-2023-0120. PubMed DOI
